These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26075267)

  • 1. Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer: a working hypothesis.
    Assinder SJ; Beniamen D; Lovicu FJ
    Biomed Res Int; 2015; 2015():827462. PubMed ID: 26075267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spry1 and Spry2 are necessary for eyelid closure.
    Kuracha MR; Siefker E; Licht JD; Govindarajan V
    Dev Biol; 2013 Nov; 383(2):227-38. PubMed ID: 24055172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of lens fiber cell differentiation by RTK antagonists Spry and Spred.
    Zhao G; Bailey CG; Feng Y; Rasko J; Lovicu FJ
    Exp Eye Res; 2018 May; 170():148-159. PubMed ID: 29501879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative and independent functions of FGF and Wnt signaling during early inner ear development.
    Wright KD; Mahoney Rogers AA; Zhang J; Shim K
    BMC Dev Biol; 2015 Oct; 15():33. PubMed ID: 26443994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprouty genes prevent excessive FGF signalling in multiple cell types throughout development of the cerebellum.
    Yu T; Yaguchi Y; Echevarria D; Martinez S; Basson MA
    Development; 2011 Jul; 138(14):2957-68. PubMed ID: 21693512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty gain of function disrupts lens cellular processes and growth by restricting RTK signaling.
    Shin EH; Zhao G; Wang Q; Lovicu FJ
    Dev Biol; 2015 Oct; 406(2):129-46. PubMed ID: 26375880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.
    Sharma B; Joshi S; Sassano A; Majchrzak B; Kaur S; Aggarwal P; Nabet B; Bulic M; Stein BL; McMahon B; Baker DP; Fukunaga R; Altman JK; Licht JD; Fish EN; Platanias LC
    J Biol Chem; 2012 Dec; 287(50):42352-60. PubMed ID: 23074222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sprouty proteins regulate ureteric branching by coordinating reciprocal epithelial Wnt11, mesenchymal Gdnf and stromal Fgf7 signalling during kidney development.
    Chi L; Zhang S; Lin Y; Prunskaite-Hyyryläinen R; Vuolteenaho R; Itäranta P; Vainio S
    Development; 2004 Jul; 131(14):3345-56. PubMed ID: 15201220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C.
    Akbulut S; Reddi AL; Aggarwal P; Ambardekar C; Canciani B; Kim MK; Hix L; Vilimas T; Mason J; Basson MA; Lovatt M; Powell J; Collins S; Quatela S; Phillips M; Licht JD
    Mol Biol Cell; 2010 Oct; 21(19):3487-96. PubMed ID: 20719962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.
    Zhang Q; Wei T; Shim K; Wright K; Xu K; Palka-Hamblin HL; Jurkevich A; Khare S
    Oncogene; 2016 Jun; 35(24):3151-62. PubMed ID: 26434583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spry1 and spry2 are essential for development of the temporomandibular joint.
    Purcell P; Jheon A; Vivero MP; Rahimi H; Joo A; Klein OD
    J Dent Res; 2012 Apr; 91(4):387-93. PubMed ID: 22328578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprouty is a cytoplasmic target of adenoviral E1A oncoproteins to regulate the receptor tyrosine kinase signalling pathway.
    Zaremba A; Schmuecker U; Esche H
    Virol J; 2011 Apr; 8():192. PubMed ID: 21518456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract.
    Shin EH; Basson MA; Robinson ML; McAvoy JW; Lovicu FJ
    Mol Med; 2012 Jul; 18(1):861-73. PubMed ID: 22517312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprouty genes function in suppression of prostate tumorigenesis.
    Schutzman JL; Martin GR
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20023-8. PubMed ID: 23150596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty genes are essential for the normal development of epibranchial ganglia in the mouse embryo.
    Simrick S; Lickert H; Basson MA
    Dev Biol; 2011 Oct; 358(1):147-55. PubMed ID: 21806979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated activity of Spry1 and Spry2 is required for normal development of the external genitalia.
    Ching ST; Cunha GR; Baskin LS; Basson MA; Klein OD
    Dev Biol; 2014 Feb; 386(1):1-11. PubMed ID: 24361260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.
    Zhang Q; Shim K; Wright K; Jurkevich A; Khare S
    Mol Carcinog; 2016 Sep; 55(9):1355-68. PubMed ID: 26293890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprouty and Spred temporally regulate ERK1/2-signaling to suppress TGFβ-induced lens EMT.
    Zhao G; Pan AY; Feng Y; Rasko JEJ; Bailey CG; Lovicu FJ
    Exp Eye Res; 2022 Jun; 219():109070. PubMed ID: 35413282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spred negatively regulates lens growth by modulating epithelial cell proliferation and fiber differentiation.
    Susanto A; Zhao G; Wazin F; Feng Y; Rasko JEJ; Bailey CG; Lovicu FJ
    Exp Eye Res; 2019 Jan; 178():160-175. PubMed ID: 30290165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.
    Kachroo N; Valencia T; Warren AY; Gnanapragasam VJ
    Br J Cancer; 2013 Feb; 108(3):597-601. PubMed ID: 23169297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.